1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9689):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-17038S
    Agomelatine-d6
    98.57%
    Agomelatine-d6 is deuterium labeled Agomelatine. Agomelatine is a specific agonist of MT1 and MT2 receptors .
    Agomelatine-d<sub>6</sub>
  • HY-10569S1
    Ponesimod-d7
    Ponesimod-d7 (ACT-128800-d7) is the deuterium-labeled Ponesimod (HY-10569). Ponesimod-d7 (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod-d7 activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod-d7 can protect against lymphocyte-mediated tissue inflammation.
    Ponesimod-d<sub>7</sub>
  • HY-W009762S2
    L-Lysine-d4 dihydrochloride
    ≥98.0%
    L-Lysine-d4 (dihydrochloride) is the deuterium labeled L-Lysine dihydrochloride.
    L-Lysine-d<sub>4</sub> dihydrochloride
  • HY-136648S1
    2'-Deoxyadenosine-5'-triphosphate-13C10,15N5 dilithium
    99.2%
    2'-Deoxyadenosine-5'-triphosphate-13C10,15N5 (dATP-13C10,15N5) dilithium is 13C and 15N-labeled 2'-Deoxyadenosine-5'-triphosphate (HY-136648). 2'-Deoxyadenosine-5'-triphosphate (dATP) is a nucleotide used in cells for DNA synthesis (or replication), as a substrate of DNA polymerase.
    2'-Deoxyadenosine-5'-triphosphate-<sup>13</sup>C<sub>10</sub>,<sup>15</sup>N<sub>5</sub> dilithium
  • HY-50904S1
    Nintedanib-13C,d3
    ≥99.0%
    Nintedanib-13C,d3 is the 13C- and deuterium labeled Nintedanib. Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.
    Nintedanib-<sup>13</sup>C,d<sub>3</sub>
  • HY-B0507S
    Sulfathiazole-d4
    99.91%
    Sulfathiazole-d4 is a deuterium labeled Sulfathiazole. Sulfathiazole is an orally active, endocrine disruptor targeting the steroidogenic pathway, specifically enhancing the activity of CYP19 in human adrenal cancer cells (H295R) and upregulating the mRN expression of CYP17, CYP19, and 3β-HSD. Sulfathiazole increases the production of 17-estradiol (E2) and has endocrine disrupting effects on aquatic organisms such as the Japanese medaka fish.
    Sulfathiazole-d<sub>4</sub>
  • HY-143915S
    Amitriptyline-N-glucuronide-d3
    Amitriptyline-N-glucuronide-d3 is the deuterium labeled Amitriptyline-N-glucuronide.
    Amitriptyline-N-glucuronide-d<sub>3</sub>
  • HY-N0092S
    Inosine-2,8-d2
    99.69%
    Inosine-2,8-d2 is the deuterium labeled Inosine. Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors.
    Inosine-2,8-d<sub>2</sub>
  • HY-N1131S
    Triacetonamine-d17
    99.72%
    Triacetonamine-d17 (2,2,6,6-Tetramethyl-4-piperidone-d17) is the deuterium labeled Triacetonamine. Triacetonamine has oral activity and can induce acute liver failure (ALF) in rats.
    Triacetonamine-d<sub>17</sub>
  • HY-17395S
    Terbinafine-d3 hydrochloride
    99.87%
    Terbinafine-d3 hydrochloride is the deuterium labeled Terbinafine hydrochloride. Terbinafine hydrochloride (TDT 067 hydrochloride) is an antifungal medication used to treat fungal infections. It is a potent non-competitive inhibitor of squalene epoxidase from Candida with a Ki of 30 nM. Terbinafine hydrochloride also antibacterial activity against certain Gram-positive and Gram-negative bacteria.
    Terbinafine-d<sub>3</sub> hydrochloride
  • HY-N0210S
    D-Galactose-13C
    ≥98.0%
    D-Galactose-13C is the 13C labeled D-Galactose. D-Galactose is a natural aldohexose and C-4 epimer of glucose.
    D-Galactose-<sup>13</sup>C
  • HY-30004S
    1-Aminocyclopropane-1-carboxylic acid-d4
    ≥99.0%
    1-Aminocyclopropane-1-carboxylic acid-d4 is the deuterium labeled 1-Aminocyclopropane-1-carboxylic acid. Aminocyclopropane-1-carboxylic acid is an endogenous metabolite[1].
    1-Aminocyclopropane-1-carboxylic acid-d<sub>4</sub>
  • HY-N7143S
    Monobutyl phthalate-d4
    99.34%
    Monobutyl phthalate-d4 is the deuterium labeled Monobutyl phthalate. Monobutyl phthalate, a major metabolite of dibutyl phthalate (DBP), possesses antiandrogenic effects. Monobutyl phthalate is an embryotoxicant.
    Monobutyl phthalate-d<sub>4</sub>
  • HY-W127841
    Citric acid-2,4-13C2
    98.00%
    Citric acid-2,4-13C2 is the 13C-labeled Citric acid (HY-N1428). Citric acid is a natural preservative and food tartness enhancer. Citric acid induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Citric acid cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid is also an acidulant, emulsifier, sequestrant and buffering agent widely used across many industries.
    Citric acid-2,4-<sup>13</sup>C<sub>2</sub>
  • HY-10863S
    Anandamide-d8
    99.90%
    Anandamide-d8 is a deuterated labeled Anandamide. Anandamide is an endocannabinoid. Anandamide modulates both neuronal and immune functions through two protein-coupled cannabinoid receptors (CB1 and CB2). Anandamide can activate numerous other receptors like PPARS, TRPV1, and GPR18/GPR55. Anandamide also has potential anti-fungal and anti-inflammatory activities. Anandamide can be used for the research of Alzheimer’s disease (AD) and ulcerative colitis.
    Anandamide-d<sub>8</sub>
  • HY-137083S
    Trifluoperazine N-glucuronide-d3
    Trifluoperazine N-glucuronide-d3 is deuterium labeled Trifluoperazine N-Glucuronide. Trifluoperazine N-Glucuronide (UGT1A4), as one of the human UGT1A isoforms, is expressed in the liver. Trifluoperazine N-Glucuronide catalyzes the imipramine and trifluoperazine Nglucuronide formation.
    Trifluoperazine N-glucuronide-d<sub>3</sub>
  • HY-Y1250S2
    Fmoc-Gly-OH-2,2-d2
    99.66%
    Fmoc-Gly-OH-2,2-d2 is the deuterium labeled Fmoc-Gly-OH-2,2.
    Fmoc-Gly-OH-2,2-d<sub>2</sub>
  • HY-B0456S3
    Riboflavin-d3
    99.40%
    Riboflavin-d3 is the deuterium labeled Riboflavin. Riboflavin is an easily absorbed micronutrient with a key role in maintaining health in humans and other animals.
    Riboflavin-d<sub>3</sub>
  • HY-B0493S1
    Niflumic acid-13C6
    99.8%
    Niflumic acid-13C6 is the 13C6 labeled Niflumic acid. Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
    Niflumic acid-<sup>13</sup>C<sub>6</sub>
  • HY-B0451AS1
    Dopamine-13C6 hydrochloride
    98.71%
    Dopamine-13C6 (hydrochloride) is the 13C labeled Dopamine hydrochloride (ASL279).
    Dopamine-<sup>13</sup>C<sub>6</sub> hydrochloride